SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,475,651 | -8.0% | 514,852 | +32.6% | 0.02% | 0.0% |
| Q2 2023 | $8,128,207 | +63.5% | 388,352 | +65.0% | 0.02% | +45.5% |
| Q1 2023 | $4,971,014 | -17.0% | 235,370 | 0.0% | 0.01% | -15.4% |
| Q4 2022 | $5,990,167 | +17.9% | 235,370 | +11.4% | 0.01% | 0.0% |
| Q3 2022 | $5,080,000 | +109.2% | 211,368 | +67.5% | 0.01% | +116.7% |
| Q2 2022 | $2,428,000 | +130.1% | 126,191 | +107.8% | 0.01% | +200.0% |
| Q1 2022 | $1,055,000 | -20.7% | 60,737 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,330,000 | -65.0% | 60,737 | -69.4% | 0.00% | -62.5% |
| Q3 2021 | $3,796,000 | +294.2% | 198,602 | +253.9% | 0.01% | +300.0% |
| Q2 2021 | $963,000 | -23.2% | 56,118 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,254,000 | +37.7% | 56,118 | +36.9% | 0.00% | +50.0% |
| Q4 2020 | $911,000 | +50.8% | 40,977 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $604,000 | +127.1% | 40,977 | +128.2% | 0.00% | +100.0% |
| Q2 2020 | $266,000 | +109.4% | 17,954 | +54.7% | 0.00% | – |
| Q1 2020 | $127,000 | -37.7% | 11,609 | -50.0% | 0.00% | -100.0% |
| Q4 2019 | $204,000 | – | 23,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
| Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
| Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
| Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
| Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
| DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
| COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
| Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |